6.
Nguyen M, An S, Nguyen Y, Hyun Y, Choi H, Pham L
. Design, Synthesis, and Biological Activity of l-1'-Homologated Adenosine Derivatives. ACS Med Chem Lett. 2022; 13(7):1131-1136.
PMC: 9290037.
DOI: 10.1021/acsmedchemlett.2c00159.
View
7.
Enosi Tuipulotu D, Fumian T, Netzler N, Mackenzie J, White P
. The Adenosine Analogue NITD008 has Potent Antiviral Activity against Human and Animal Caliciviruses. Viruses. 2019; 11(6).
PMC: 6631109.
DOI: 10.3390/v11060496.
View
8.
Koraboina C, Akshinthala P, Kumar Katari N, Adarasandi R, Babu Jonnalagadda S, Gundla R
. New oxindole carboxamides as inhibitors of DENV NS5 RdRp: Design, synthesis, docking and Biochemical characterization. Heliyon. 2023; 9(11):e21510.
PMC: 10665688.
DOI: 10.1016/j.heliyon.2023.e21510.
View
9.
Brady O, Hay S
. The Global Expansion of Dengue: How Mosquitoes Enabled the First Pandemic Arbovirus. Annu Rev Entomol. 2019; 65:191-208.
DOI: 10.1146/annurev-ento-011019-024918.
View
10.
Bhatnagar P, Sreekanth G, Murali-Krishna K, Chandele A, Sitaraman R
. Dengue Virus Non-Structural Protein 5 as a Versatile, Multi-Functional Effector in Host-Pathogen Interactions. Front Cell Infect Microbiol. 2021; 11:574067.
PMC: 8015806.
DOI: 10.3389/fcimb.2021.574067.
View
11.
Warren T, Wells J, Panchal R, Stuthman K, Garza N, Van Tongeren S
. Protection against filovirus diseases by a novel broad-spectrum nucleoside analogue BCX4430. Nature. 2014; 508(7496):402-5.
PMC: 7095208.
DOI: 10.1038/nature13027.
View
12.
Tully D, Griffiths C
. Dengvaxia: the world's first vaccine for prevention of secondary dengue. Ther Adv Vaccines Immunother. 2021; 9:25151355211015839.
PMC: 8132086.
DOI: 10.1177/25151355211015839.
View
13.
Humphrey W, Dalke A, Schulten K
. VMD: visual molecular dynamics. J Mol Graph. 1996; 14(1):33-8, 27-8.
DOI: 10.1016/0263-7855(96)00018-5.
View
14.
Pheng Lim S, Noble C, Shi P
. The dengue virus NS5 protein as a target for drug discovery. Antiviral Res. 2015; 119:57-67.
DOI: 10.1016/j.antiviral.2015.04.010.
View
15.
Maier J, Martinez C, Kasavajhala K, Wickstrom L, Hauser K, Simmerling C
. ff14SB: Improving the Accuracy of Protein Side Chain and Backbone Parameters from ff99SB. J Chem Theory Comput. 2015; 11(8):3696-713.
PMC: 4821407.
DOI: 10.1021/acs.jctc.5b00255.
View
16.
Bhatt S, Gething P, Brady O, Messina J, Farlow A, Moyes C
. The global distribution and burden of dengue. Nature. 2013; 496(7446):504-7.
PMC: 3651993.
DOI: 10.1038/nature12060.
View
17.
Noble C, Pheng Lim S, Arora R, Yokokawa F, Nilar S, Seh C
. A Conserved Pocket in the Dengue Virus Polymerase Identified through Fragment-based Screening. J Biol Chem. 2016; 291(16):8541-8.
PMC: 4861426.
DOI: 10.1074/jbc.M115.710731.
View
18.
Yin Z, Chen Y, Schul W, Wang Q, Gu F, Duraiswamy J
. An adenosine nucleoside inhibitor of dengue virus. Proc Natl Acad Sci U S A. 2009; 106(48):20435-9.
PMC: 2787148.
DOI: 10.1073/pnas.0907010106.
View
19.
Shepard D, Undurraga E, Halasa Y, Stanaway J
. The global economic burden of dengue: a systematic analysis. Lancet Infect Dis. 2016; 16(8):935-41.
DOI: 10.1016/S1473-3099(16)00146-8.
View
20.
Nascimento I, Santos-Junior P, Aquino T, Araujo-Junior J, Silva-Junior E
. Insights on Dengue and Zika NS5 RNA-dependent RNA polymerase (RdRp) inhibitors. Eur J Med Chem. 2021; 224:113698.
DOI: 10.1016/j.ejmech.2021.113698.
View